Ironwood Pharmaceuticals

Ironwood spies new frontier for $1B GLP-2 analog in exploratory phase 2 rare disease trial
Fierce Biotech
Thu, 03/28/24 - 11:16 am
Ironwood Pharmaceuticals
apraglutide
VectaBio
graft vs host disease
Pipeline moves: Approval prospects for SBS candidate rise after Phase III trial meets endpoints
Clinical Trials Arena
Mon, 03/18/24 - 11:09 am
Ironwood Pharmaceuticals
short bowel syndrome
clinical trials
apraglutide
FDA approves 1st pediatric drug for functional constipation
Beckers Hospital Review
Tue, 06/13/23 - 10:58 pm
Ironwood Pharmaceuticals
FDA
Linzess
pediatric
constipation
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Ironwood to buy VectivBio for $1.15 billion to boost digestive disorder drugs portfolio
Yahoo/Reuters
Mon, 05/22/23 - 10:27 am
Ironwood Pharmaceuticals
VectivBio
M&A
digestive disorders
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Yahoo/Benzinga
Mon, 02/15/21 - 10:37 am
earnings
FDA
G1 Therapeutics
trilaciclib
Zoetis
EXACT Sciences
Blueprint Medicines
Ironwood Pharmaceuticals
The doctor will Zoom you now: Pharma execs talk ins and outs of telehealth
Fierce Pharma
Fri, 10/30/20 - 10:45 am
telehealth
telemedicine
Ironwood Pharmaceuticals
Evofem Biosciences
Linzess
Phexxi
pharma marketing
Ironwood puts GERD hopeful on the chopping block, along with 100 staffers after flop
Fierce Biotech
Tue, 09/29/20 - 12:30 pm
Ironwood Pharmaceuticals
IW-3718
layoffs
GERD
Ironwood, Allergan adds a slate of PhIIIb data to its Linzess pitch for physicians, patients
Endpoints
Wed, 06/19/19 - 09:49 am
Ironwood Pharmaceuticals
Allergan
Linzess
clinical trials
IBS-C
Ironwood Pharma Spins off Cyclerion Therapeutics With 5 Orphan Disease Compounds
BioSpace
Tue, 04/2/19 - 12:02 pm
Ironwood Pharmaceuticals
Cyclerion
spinoffs
orphan diseases
14 Drugs Earn Billions for These Massachusetts Biotechs
BioSpace
Wed, 03/6/19 - 09:59 am
Massachusetts
Boston
Biogen
Tecfidera
Benepali
Shire
Takeda
Vyvanse
Vertex Pharmaceuticals
Orkambi
Kalydeco
Alexion
Soliris
Strensiq
Sanofi Genzyme
Lantus
Ironwood Pharmaceuticals
Linzess
Ironwood spinout Cyclerion planning $175M private placement
BioCentury
Tue, 02/26/19 - 11:52 pm
Cyclerion
Ironwood Pharmaceuticals
Ironwood to cut 35 more jobs as company split nears
BioPharma Dive
Wed, 02/13/19 - 04:52 pm
Ironwood Pharmaceuticals
layoffs
spinoffs
Cyclerion
Ironwood Pharmaceuticals initiates phase 1 trial of IW-6463
Pharmaceutical Business Review
Thu, 01/24/19 - 10:55 am
Ironwood Pharmaceuticals
IW-6463
CNS disorders
clinical trials
Ironwood names AstraZeneca exec as CEO; shares up 8%
Seeking Alpha
Sat, 01/5/19 - 01:41 pm
Ironwood Pharmaceuticals
AstraZeneca
Mark Mallon
Ironwood, Allergan set to resolve LINZESS patent litigation with Mylan
Pharmaceutical Business Review
Thu, 01/3/19 - 09:40 am
Ironwood Pharmaceuticals
Mylan
patents
Linzess
Novartis May Beat Ironwood Pharmaceuticals to the Punch
Motley Fool
Tue, 10/30/18 - 11:17 pm
Novartis
crizanlizumab
sickle cell disease
Ironwood Pharmaceuticals
IW-1701
Ironwood secures FDA fast track designation for heart drug praliciguat
Pharmaceutical Business Review
Fri, 09/14/18 - 09:44 am
Ironwood Pharmaceuticals
FDA
praliciguat
heart failure
Linzess Receives Additional Indication in Japan for Chronic Constipation
Tue, 08/21/18 - 09:38 am
Astellas
Ironwood Pharmaceuticals
Linzess
Ironwood Initiates Ph III Study of Linaclotide in IBS-C
CP Wire
Mon, 07/16/18 - 09:08 am
Ironwood Pharmaceuticals
Allergan
linaclotide
Linzess
IBS-C

Pages